鼻腔用ワクチンの世界市場インサイト、2029年までの予測Global Nasal Vaccines Market Insights, Forecast to 2029 鼻腔用ワクチンの世界市場は、予測期間中に年平均成長率(CAGR)%で、2023年の百万米ドルから2029年には百万米ドルに達すると予測されます。 鼻腔用ワクチンの米国・カナダ市場は、2023年の100万ドルから2029年... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー鼻腔用ワクチンの世界市場は、予測期間中に年平均成長率(CAGR)%で、2023年の百万米ドルから2029年には百万米ドルに達すると予測されます。鼻腔用ワクチンの米国・カナダ市場は、2023年の100万ドルから2029年には100万ドルに達すると予測され、2023年から2029年の予測期間中にCAGR %で増加すると予測されます。 鼻腔用ワクチンの中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年までの予測期間中にCAGR %で増加するとされています。 鼻腔用ワクチンのヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加するとされています。 鼻腔用ワクチンの世界の主要メーカーは、Sanofi、AstraZeneca、Abbott、GlaxoSmithKline、Serum Institute of India、Bharat Biotech、Antares Pharma、INJEX Pharma GmbHおよびBioDiemなどです。2022年、世界の上位5社は、売上高で約 %のシェアを占めていました。 レポートには、以下の内容が含まれています: 本レポートでは、鼻腔用ワクチンの世界市場の概要、売上、収益、価格などを紹介しています。2018年~2022年の過去の市場収益/売上データ、2023年の予測、2029年までのCAGRの予測など、世界市場動向の分析も行っています。 本レポートでは、鼻腔用ワクチンの主要生産者を調査し、主要地域と国の売上高も掲載しています。鼻腔用ワクチンの今後の市場可能性のハイライト、およびこの市場を様々なセグメントとサブセグメントに分けて予測するための主要地域/国への注目点。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データおよび市場価値分析。 本レポートでは、2018年から2023年のデータをもとに、鼻腔用ワクチンの売上、収益、主要メーカーの市場シェア、業界ランキングに焦点を当てます。世界の鼻腔用ワクチン市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、事業や市場戦略をより良い形で位置づけるのに役立つと思われます。 本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、売上、収益、価格を分析しています。鼻腔用ワクチンの売上、予測される成長動向、生産技術、用途、エンドユーザー産業の評価と市場規模を予測します。 サノフィ、アストラゼネカ、アボット、グラクソ・スミスクライン、Serum Institute of India、Bharat Biotech、Antares Pharma、INJEX Pharma GmbH、BioDiemなど、世界の主要プレイヤーの説明的企業プロフィール。 会社別 サノフィ アストラゼネカ アボット グラクソ・スミスクライン セラム・インスティテュート・オブ・インディア バーラト・バイオテック アンタレスファーマ INJEX Pharma GmbH バイオディエム ファーマジェットとクロスジェクト タイプ別セグメント インフルエンザワクチン COVID-19ワクチン その他のワクチン 用途別セグメント アダルト 子どもたち 地域別セグメント アメリカ・カナダ U.S. カナダ 中国 アジア(中国を除く) 日本 南朝鮮 中国 台湾 東南アジア インド ヨーロッパ ドイツ フランス イギリス イタリア ロシア 中近東、アフリカ、中南米 ブラジル メキシコ トルコ イスラエル GCC諸国 章立て 第1章:報告書のスコープ、市場セグメント別(タイプ別、用途別など)のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介。市場の現状と、短中期および長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな視点で解説しています。 第2章 鼻腔用ワクチンの世界、地域レベル、国レベルでの販売(消費)、収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見通し、市場スペース、生産能力などを紹介しています。 第3章:鼻腔ワクチンメーカーの競争環境、価格、販売、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。 第4章:各種市場セグメントを種類別に分析し、各市場セグメントの売上高、収益、平均価格、発展可能性を網羅し、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。 第5章:読者が異なる下流市場でブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーする、様々な市場セグメントのアプリケーションの分析を提供します。 第6章:米国とカナダ(US & Canada)タイプ別、アプリケーション別、国別、各セグメント別の売上と収益。 第7章:ヨーロッパ(Europe):タイプ別、アプリケーション別、国別、セグメント別の売上高と収益。 第8章:中国 種類別、用途別、国別、各セグメント別の売上と収益。 第9章:アジア(中国を除く) タイプ別、アプリケーション別、地域別、各セグメント別の売上と収益。 第10章:中東、アフリカ、中南米:タイプ別、アプリケーション別、国別、各セグメント別の売上高と収益。 第11章:主要メーカーのプロファイルを提供し、製品の説明と仕様、鼻腔ワクチンの売上、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。 第12章:産業チェーン、販売チャネル、主要原材料、流通業者、顧客に関する分析。 第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界メーカーが直面する課題とリスク、業界の関連政策の分析などを紹介します。 第14章:本レポートの要点と結論。 目次1 Study Coverage1.1 Nasal Vaccines Product Introduction 1.2 Market by Type 1.2.1 Global Nasal Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Flu Vaccines 1.2.3 COVID-19 Vaccines 1.2.4 Other Vaccines 1.3 Market by Application 1.3.1 Global Nasal Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Adult 1.3.3 Children 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Nasal Vaccines Sales Estimates and Forecasts 2018-2029 2.2 Global Nasal Vaccines Revenue by Region 2.2.1 Global Nasal Vaccines Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global Nasal Vaccines Revenue by Region (2018-2023) 2.2.3 Global Nasal Vaccines Revenue by Region (2024-2029) 2.2.4 Global Nasal Vaccines Revenue Market Share by Region (2018-2029) 2.3 Global Nasal Vaccines Sales Estimates and Forecasts 2018-2029 2.4 Global Nasal Vaccines Sales by Region 2.4.1 Global Nasal Vaccines Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global Nasal Vaccines Sales by Region (2018-2023) 2.4.3 Global Nasal Vaccines Sales by Region (2024-2029) 2.4.4 Global Nasal Vaccines Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Nasal Vaccines Sales by Manufacturers 3.1.1 Global Nasal Vaccines Sales by Manufacturers (2018-2023) 3.1.2 Global Nasal Vaccines Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nasal Vaccines in 2022 3.2 Global Nasal Vaccines Revenue by Manufacturers 3.2.1 Global Nasal Vaccines Revenue by Manufacturers (2018-2023) 3.2.2 Global Nasal Vaccines Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by Nasal Vaccines Revenue in 2022 3.3 Global Key Players of Nasal Vaccines, Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global Nasal Vaccines Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Nasal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Nasal Vaccines, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Nasal Vaccines, Product Offered and Application 3.8 Global Key Manufacturers of Nasal Vaccines, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Nasal Vaccines Sales by Type 4.1.1 Global Nasal Vaccines Historical Sales by Type (2018-2023) 4.1.2 Global Nasal Vaccines Forecasted Sales by Type (2024-2029) 4.1.3 Global Nasal Vaccines Sales Market Share by Type (2018-2029) 4.2 Global Nasal Vaccines Revenue by Type 4.2.1 Global Nasal Vaccines Historical Revenue by Type (2018-2023) 4.2.2 Global Nasal Vaccines Forecasted Revenue by Type (2024-2029) 4.2.3 Global Nasal Vaccines Revenue Market Share by Type (2018-2029) 4.3 Global Nasal Vaccines Price by Type 4.3.1 Global Nasal Vaccines Price by Type (2018-2023) 4.3.2 Global Nasal Vaccines Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global Nasal Vaccines Sales by Application 5.1.1 Global Nasal Vaccines Historical Sales by Application (2018-2023) 5.1.2 Global Nasal Vaccines Forecasted Sales by Application (2024-2029) 5.1.3 Global Nasal Vaccines Sales Market Share by Application (2018-2029) 5.2 Global Nasal Vaccines Revenue by Application 5.2.1 Global Nasal Vaccines Historical Revenue by Application (2018-2023) 5.2.2 Global Nasal Vaccines Forecasted Revenue by Application (2024-2029) 5.2.3 Global Nasal Vaccines Revenue Market Share by Application (2018-2029) 5.3 Global Nasal Vaccines Price by Application 5.3.1 Global Nasal Vaccines Price by Application (2018-2023) 5.3.2 Global Nasal Vaccines Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada Nasal Vaccines Market Size by Type 6.1.1 US & Canada Nasal Vaccines Sales by Type (2018-2029) 6.1.2 US & Canada Nasal Vaccines Revenue by Type (2018-2029) 6.2 US & Canada Nasal Vaccines Market Size by Application 6.2.1 US & Canada Nasal Vaccines Sales by Application (2018-2029) 6.2.2 US & Canada Nasal Vaccines Revenue by Application (2018-2029) 6.3 US & Canada Nasal Vaccines Market Size by Country 6.3.1 US & Canada Nasal Vaccines Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada Nasal Vaccines Sales by Country (2018-2029) 6.3.3 US & Canada Nasal Vaccines Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Nasal Vaccines Market Size by Type 7.1.1 Europe Nasal Vaccines Sales by Type (2018-2029) 7.1.2 Europe Nasal Vaccines Revenue by Type (2018-2029) 7.2 Europe Nasal Vaccines Market Size by Application 7.2.1 Europe Nasal Vaccines Sales by Application (2018-2029) 7.2.2 Europe Nasal Vaccines Revenue by Application (2018-2029) 7.3 Europe Nasal Vaccines Market Size by Country 7.3.1 Europe Nasal Vaccines Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe Nasal Vaccines Sales by Country (2018-2029) 7.3.3 Europe Nasal Vaccines Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Nasal Vaccines Market Size 8.1.1 China Nasal Vaccines Sales (2018-2029) 8.1.2 China Nasal Vaccines Revenue (2018-2029) 8.2 China Nasal Vaccines Market Size by Application 8.2.1 China Nasal Vaccines Sales by Application (2018-2029) 8.2.2 China Nasal Vaccines Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Nasal Vaccines Market Size by Type 9.1.1 Asia Nasal Vaccines Sales by Type (2018-2029) 9.1.2 Asia Nasal Vaccines Revenue by Type (2018-2029) 9.2 Asia Nasal Vaccines Market Size by Application 9.2.1 Asia Nasal Vaccines Sales by Application (2018-2029) 9.2.2 Asia Nasal Vaccines Revenue by Application (2018-2029) 9.3 Asia Nasal Vaccines Sales by Region 9.3.1 Asia Nasal Vaccines Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia Nasal Vaccines Revenue by Region (2018-2029) 9.3.3 Asia Nasal Vaccines Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Nasal Vaccines Market Size by Type 10.1.1 Middle East, Africa and Latin America Nasal Vaccines Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America Nasal Vaccines Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America Nasal Vaccines Market Size by Application 10.2.1 Middle East, Africa and Latin America Nasal Vaccines Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America Nasal Vaccines Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America Nasal Vaccines Sales by Country 10.3.1 Middle East, Africa and Latin America Nasal Vaccines Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America Nasal Vaccines Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America Nasal Vaccines Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Company Information 11.1.2 Sanofi Overview 11.1.3 Sanofi Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 Sanofi Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Sanofi Recent Developments 11.2 AstraZeneca 11.2.1 AstraZeneca Company Information 11.2.2 AstraZeneca Overview 11.2.3 AstraZeneca Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 AstraZeneca Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 AstraZeneca Recent Developments 11.3 Abbott 11.3.1 Abbott Company Information 11.3.2 Abbott Overview 11.3.3 Abbott Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Abbott Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Abbott Recent Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Information 11.4.2 GlaxoSmithKline Overview 11.4.3 GlaxoSmithKline Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 GlaxoSmithKline Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 GlaxoSmithKline Recent Developments 11.5 Serum Institute of India 11.5.1 Serum Institute of India Company Information 11.5.2 Serum Institute of India Overview 11.5.3 Serum Institute of India Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Serum Institute of India Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Serum Institute of India Recent Developments 11.6 Bharat Biotech 11.6.1 Bharat Biotech Company Information 11.6.2 Bharat Biotech Overview 11.6.3 Bharat Biotech Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.6.4 Bharat Biotech Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bharat Biotech Recent Developments 11.7 Antares Pharma 11.7.1 Antares Pharma Company Information 11.7.2 Antares Pharma Overview 11.7.3 Antares Pharma Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.7.4 Antares Pharma Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Antares Pharma Recent Developments 11.8 INJEX Pharma GmbH 11.8.1 INJEX Pharma GmbH Company Information 11.8.2 INJEX Pharma GmbH Overview 11.8.3 INJEX Pharma GmbH Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.8.4 INJEX Pharma GmbH Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 INJEX Pharma GmbH Recent Developments 11.9 BioDiem 11.9.1 BioDiem Company Information 11.9.2 BioDiem Overview 11.9.3 BioDiem Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.9.4 BioDiem Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 BioDiem Recent Developments 11.10 PharmaJet and Crossject 11.10.1 PharmaJet and Crossject Company Information 11.10.2 PharmaJet and Crossject Overview 11.10.3 PharmaJet and Crossject Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.10.4 PharmaJet and Crossject Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 PharmaJet and Crossject Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Nasal Vaccines Industry Chain Analysis 12.2 Nasal Vaccines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Nasal Vaccines Production Mode & Process 12.4 Nasal Vaccines Sales and Marketing 12.4.1 Nasal Vaccines Sales Channels 12.4.2 Nasal Vaccines Distributors 12.5 Nasal Vaccines Customers 13 Market Dynamics 13.1 Nasal Vaccines Industry Trends 13.2 Nasal Vaccines Market Drivers 13.3 Nasal Vaccines Market Challenges 13.4 Nasal Vaccines Market Restraints 14 Key Findings in The Global Nasal Vaccines Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryThe global Nasal Vaccines market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Table of Contents1 Study Coverage1.1 Nasal Vaccines Product Introduction 1.2 Market by Type 1.2.1 Global Nasal Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 1.2.2 Flu Vaccines 1.2.3 COVID-19 Vaccines 1.2.4 Other Vaccines 1.3 Market by Application 1.3.1 Global Nasal Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 1.3.2 Adult 1.3.3 Children 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Executive Summary 2.1 Global Nasal Vaccines Sales Estimates and Forecasts 2018-2029 2.2 Global Nasal Vaccines Revenue by Region 2.2.1 Global Nasal Vaccines Revenue by Region: 2018 VS 2022 VS 2029 2.2.2 Global Nasal Vaccines Revenue by Region (2018-2023) 2.2.3 Global Nasal Vaccines Revenue by Region (2024-2029) 2.2.4 Global Nasal Vaccines Revenue Market Share by Region (2018-2029) 2.3 Global Nasal Vaccines Sales Estimates and Forecasts 2018-2029 2.4 Global Nasal Vaccines Sales by Region 2.4.1 Global Nasal Vaccines Sales by Region: 2018 VS 2022 VS 2029 2.4.2 Global Nasal Vaccines Sales by Region (2018-2023) 2.4.3 Global Nasal Vaccines Sales by Region (2024-2029) 2.4.4 Global Nasal Vaccines Sales Market Share by Region (2018-2029) 2.5 US & Canada 2.6 Europe 2.7 China 2.8 Asia (excluding China) 2.9 Middle East, Africa and Latin America 3 Competition by Manufactures 3.1 Global Nasal Vaccines Sales by Manufacturers 3.1.1 Global Nasal Vaccines Sales by Manufacturers (2018-2023) 3.1.2 Global Nasal Vaccines Sales Market Share by Manufacturers (2018-2023) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nasal Vaccines in 2022 3.2 Global Nasal Vaccines Revenue by Manufacturers 3.2.1 Global Nasal Vaccines Revenue by Manufacturers (2018-2023) 3.2.2 Global Nasal Vaccines Revenue Market Share by Manufacturers (2018-2023) 3.2.3 Global Top 10 and Top 5 Companies by Nasal Vaccines Revenue in 2022 3.3 Global Key Players of Nasal Vaccines, Industry Ranking, 2021 VS 2022 VS 2023 3.4 Global Nasal Vaccines Sales Price by Manufacturers 3.5 Analysis of Competitive Landscape 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.5.2 Global Nasal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global Key Manufacturers of Nasal Vaccines, Manufacturing Base Distribution and Headquarters 3.7 Global Key Manufacturers of Nasal Vaccines, Product Offered and Application 3.8 Global Key Manufacturers of Nasal Vaccines, Date of Enter into This Industry 3.9 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Nasal Vaccines Sales by Type 4.1.1 Global Nasal Vaccines Historical Sales by Type (2018-2023) 4.1.2 Global Nasal Vaccines Forecasted Sales by Type (2024-2029) 4.1.3 Global Nasal Vaccines Sales Market Share by Type (2018-2029) 4.2 Global Nasal Vaccines Revenue by Type 4.2.1 Global Nasal Vaccines Historical Revenue by Type (2018-2023) 4.2.2 Global Nasal Vaccines Forecasted Revenue by Type (2024-2029) 4.2.3 Global Nasal Vaccines Revenue Market Share by Type (2018-2029) 4.3 Global Nasal Vaccines Price by Type 4.3.1 Global Nasal Vaccines Price by Type (2018-2023) 4.3.2 Global Nasal Vaccines Price Forecast by Type (2024-2029) 5 Market Size by Application 5.1 Global Nasal Vaccines Sales by Application 5.1.1 Global Nasal Vaccines Historical Sales by Application (2018-2023) 5.1.2 Global Nasal Vaccines Forecasted Sales by Application (2024-2029) 5.1.3 Global Nasal Vaccines Sales Market Share by Application (2018-2029) 5.2 Global Nasal Vaccines Revenue by Application 5.2.1 Global Nasal Vaccines Historical Revenue by Application (2018-2023) 5.2.2 Global Nasal Vaccines Forecasted Revenue by Application (2024-2029) 5.2.3 Global Nasal Vaccines Revenue Market Share by Application (2018-2029) 5.3 Global Nasal Vaccines Price by Application 5.3.1 Global Nasal Vaccines Price by Application (2018-2023) 5.3.2 Global Nasal Vaccines Price Forecast by Application (2024-2029) 6 US & Canada 6.1 US & Canada Nasal Vaccines Market Size by Type 6.1.1 US & Canada Nasal Vaccines Sales by Type (2018-2029) 6.1.2 US & Canada Nasal Vaccines Revenue by Type (2018-2029) 6.2 US & Canada Nasal Vaccines Market Size by Application 6.2.1 US & Canada Nasal Vaccines Sales by Application (2018-2029) 6.2.2 US & Canada Nasal Vaccines Revenue by Application (2018-2029) 6.3 US & Canada Nasal Vaccines Market Size by Country 6.3.1 US & Canada Nasal Vaccines Revenue by Country: 2018 VS 2022 VS 2029 6.3.2 US & Canada Nasal Vaccines Sales by Country (2018-2029) 6.3.3 US & Canada Nasal Vaccines Revenue by Country (2018-2029) 6.3.4 US 6.3.5 Canada 7 Europe 7.1 Europe Nasal Vaccines Market Size by Type 7.1.1 Europe Nasal Vaccines Sales by Type (2018-2029) 7.1.2 Europe Nasal Vaccines Revenue by Type (2018-2029) 7.2 Europe Nasal Vaccines Market Size by Application 7.2.1 Europe Nasal Vaccines Sales by Application (2018-2029) 7.2.2 Europe Nasal Vaccines Revenue by Application (2018-2029) 7.3 Europe Nasal Vaccines Market Size by Country 7.3.1 Europe Nasal Vaccines Revenue by Country: 2018 VS 2022 VS 2029 7.3.2 Europe Nasal Vaccines Sales by Country (2018-2029) 7.3.3 Europe Nasal Vaccines Revenue by Country (2018-2029) 7.3.4 Germany 7.3.5 France 7.3.6 U.K. 7.3.7 Italy 7.3.8 Russia 8 China 8.1 China Nasal Vaccines Market Size 8.1.1 China Nasal Vaccines Sales (2018-2029) 8.1.2 China Nasal Vaccines Revenue (2018-2029) 8.2 China Nasal Vaccines Market Size by Application 8.2.1 China Nasal Vaccines Sales by Application (2018-2029) 8.2.2 China Nasal Vaccines Revenue by Application (2018-2029) 9 Asia (excluding China) 9.1 Asia Nasal Vaccines Market Size by Type 9.1.1 Asia Nasal Vaccines Sales by Type (2018-2029) 9.1.2 Asia Nasal Vaccines Revenue by Type (2018-2029) 9.2 Asia Nasal Vaccines Market Size by Application 9.2.1 Asia Nasal Vaccines Sales by Application (2018-2029) 9.2.2 Asia Nasal Vaccines Revenue by Application (2018-2029) 9.3 Asia Nasal Vaccines Sales by Region 9.3.1 Asia Nasal Vaccines Revenue by Region: 2018 VS 2022 VS 2029 9.3.2 Asia Nasal Vaccines Revenue by Region (2018-2029) 9.3.3 Asia Nasal Vaccines Sales by Region (2018-2029) 9.3.4 Japan 9.3.5 South Korea 9.3.6 China Taiwan 9.3.7 Southeast Asia 9.3.8 India 10 Middle East, Africa and Latin America 10.1 Middle East, Africa and Latin America Nasal Vaccines Market Size by Type 10.1.1 Middle East, Africa and Latin America Nasal Vaccines Sales by Type (2018-2029) 10.1.2 Middle East, Africa and Latin America Nasal Vaccines Revenue by Type (2018-2029) 10.2 Middle East, Africa and Latin America Nasal Vaccines Market Size by Application 10.2.1 Middle East, Africa and Latin America Nasal Vaccines Sales by Application (2018-2029) 10.2.2 Middle East, Africa and Latin America Nasal Vaccines Revenue by Application (2018-2029) 10.3 Middle East, Africa and Latin America Nasal Vaccines Sales by Country 10.3.1 Middle East, Africa and Latin America Nasal Vaccines Revenue by Country: 2018 VS 2022 VS 2029 10.3.2 Middle East, Africa and Latin America Nasal Vaccines Revenue by Country (2018-2029) 10.3.3 Middle East, Africa and Latin America Nasal Vaccines Sales by Country (2018-2029) 10.3.4 Brazil 10.3.5 Mexico 10.3.6 Turkey 10.3.7 Israel 10.3.8 GCC Countries 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Company Information 11.1.2 Sanofi Overview 11.1.3 Sanofi Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.1.4 Sanofi Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Sanofi Recent Developments 11.2 AstraZeneca 11.2.1 AstraZeneca Company Information 11.2.2 AstraZeneca Overview 11.2.3 AstraZeneca Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.2.4 AstraZeneca Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 AstraZeneca Recent Developments 11.3 Abbott 11.3.1 Abbott Company Information 11.3.2 Abbott Overview 11.3.3 Abbott Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.3.4 Abbott Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Abbott Recent Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Information 11.4.2 GlaxoSmithKline Overview 11.4.3 GlaxoSmithKline Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.4.4 GlaxoSmithKline Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 GlaxoSmithKline Recent Developments 11.5 Serum Institute of India 11.5.1 Serum Institute of India Company Information 11.5.2 Serum Institute of India Overview 11.5.3 Serum Institute of India Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.5.4 Serum Institute of India Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Serum Institute of India Recent Developments 11.6 Bharat Biotech 11.6.1 Bharat Biotech Company Information 11.6.2 Bharat Biotech Overview 11.6.3 Bharat Biotech Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.6.4 Bharat Biotech Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Bharat Biotech Recent Developments 11.7 Antares Pharma 11.7.1 Antares Pharma Company Information 11.7.2 Antares Pharma Overview 11.7.3 Antares Pharma Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.7.4 Antares Pharma Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Antares Pharma Recent Developments 11.8 INJEX Pharma GmbH 11.8.1 INJEX Pharma GmbH Company Information 11.8.2 INJEX Pharma GmbH Overview 11.8.3 INJEX Pharma GmbH Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.8.4 INJEX Pharma GmbH Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 INJEX Pharma GmbH Recent Developments 11.9 BioDiem 11.9.1 BioDiem Company Information 11.9.2 BioDiem Overview 11.9.3 BioDiem Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.9.4 BioDiem Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.9.5 BioDiem Recent Developments 11.10 PharmaJet and Crossject 11.10.1 PharmaJet and Crossject Company Information 11.10.2 PharmaJet and Crossject Overview 11.10.3 PharmaJet and Crossject Nasal Vaccines Sales, Price, Revenue and Gross Margin (2018-2023) 11.10.4 PharmaJet and Crossject Nasal Vaccines Product Model Numbers, Pictures, Descriptions and Specifications 11.10.5 PharmaJet and Crossject Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Nasal Vaccines Industry Chain Analysis 12.2 Nasal Vaccines Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Nasal Vaccines Production Mode & Process 12.4 Nasal Vaccines Sales and Marketing 12.4.1 Nasal Vaccines Sales Channels 12.4.2 Nasal Vaccines Distributors 12.5 Nasal Vaccines Customers 13 Market Dynamics 13.1 Nasal Vaccines Industry Trends 13.2 Nasal Vaccines Market Drivers 13.3 Nasal Vaccines Market Challenges 13.4 Nasal Vaccines Market Restraints 14 Key Findings in The Global Nasal Vaccines Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(抗生物薬)の最新刊レポートQYResearch 社の最新刊レポート本レポートと同じKEY WORD(vaccines)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/12 10:27 143.85 円 158.71 円 190.22 円 |